Neutral Tandem, Inc. | TalkMarkets

Latest Posts

DexCom: A Winner In Diabetes Management

Article By: MoneyShow.com

Sunday, February 25, 2024 1:00 PM EDT

Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820 million a year ago. Can it go even higher?

In this article: DXCM Also: LLY, NVO, PODD, TNDM

Read

The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO

Article By: Benzinga

Friday, August 21, 2020 7:41 AM EDT

Covering today's biggest news in biotech, including upcoming IPO's and which stocks are hitting their 52 week high and lows.

In this article: XERS, AZN, JNJ, PFE, ALPMY, SRNE, EARS, GMAB, BNTX, TLSA, RNLX, KYMR Also: UBX, TRIL, TNDM, MMSI, PACB, REPH, FLGT, FBIO, OTIC, TLGT, SWAV, ALEC, ITRM, CSTL, ATXI, TXG, SONN, KROS, CRDF, NRIX, POAI, PCVX, ENTX, HRMY, HSTO, INBX, NAOV

Read

5 High-Flying Stocks Set To Beat On Q4 Earnings Next Week

Article By: Zacks Investment Research

Thursday, February 20, 2020 11:00 PM EDT

Here are five companies that are expected to soar after their earnings release next week.

In this article: TNDM, PZZA, ALRM, FOXF, BMCH

Read

Stock Charts To Watch - Thursday, February 13

Video By: Harry Boxer

Thursday, February 13, 2020 9:00 PM EDT

Adaptimmune Therapeutics plc is a stock I gave you after it popped, pulled back, and decided to pop again, but it hasn’t started to follow through yet.

In this video: UIS, AVXL, TNDM, AMKR, ADAP, MAXR

Watch